STI Pharma is a specialty pharmaceutical company founded in 2008 with the slogan "One Focus : Access." The company's main focus revolves around the acquisition, development, and marketing of high-quality pharmaceutical products, particularly within the oncology and injectables sector. With its headquarters based in the United States, STI Pharma operates within the Manufacturing and Pharmaceutical industries. Despite being a promising venture, it appears that the company has not received a disclosed last investment nor identified investors. STI Pharma's targeted approach and specialized focus indicate potential for significant impact in the pharmaceutical field.
There is no investment information
No recent news or press coverage available for STI PHARMA.